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The latent viral load is the most important factor that predicts reactivation rates of animals latently infected with herpes simplex virus (HSV).
To estimate the latent viral load, individual latently infected mouse trigeminal ganglia were dispersed into single cell suspensions and plated into
96-well real-time PCR plates, and HSV-2 genome copies were measured. By assuming a Poisson distribution for both the number of HSV-2
infected cells per well and the number of HSV-2 genome copies per infected cell, the numbers of infected cells and mean genome copies per
infected cell were determined. Both the number of HSV-2 infected cells and the mean HSV-2 genome copy per infected cell significantly
correlated with the latent viral load (pb10−4), indicating that both factors are responsible for the increase in the latent viral load.
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modelIntroduction
Herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) establish
lifelong latent infections in sensory neurons that are punctuated
by episodes of symptomatic and asymptomatic reactivations
(Gupta et al., 2004; Koelle and Corey, 2003; Rouse and Kaistha,
2006; Stanberry et al., 1999). The latent viral load – the total
quantity of viral genomes in a sensory ganglion – appears to
remain stable over time (Hill et al., 1996), to be proportional to
the titer of the infectious inoculum, and to correlate directly with
rates of virus reactivation in explant ganglia (Hoshino et al.,
2007; Maggioncalda et al., 1996) or in the guinea pig model
(Hoshino et al., 2005; Lekstrom-Himes et al., 1998), although
O'Neil et al. reported that the latent viral load in ganglia was
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doi:10.1016/j.virol.2007.10.0312004). Current data indicate that latency is established in only a
small percentage of all sensory neurons in non-immunocom-
promised humans (Wang et al., 2005). Moreover, the number of
copies of HSV-1 genomes residing in each human latently
infected neuron is modest (2–50 copies/cell) in most infected
cells, based on estimates using quantitative PCR of single cells
recovered from dissociated ganglia or by laser capture
microdissection (Cai et al., 2002; Wang et al., 2005). Some
neurons from humans (Wang et al., 2005) and experimentally
infected mice (Chen et al., 2002; Sawtell, 1997; Sawtell et al.,
2001) may contain ≥1000 copies of HSV-1 genomes per cell.
We sought to more fully define the determinants of the latent
viral load for HSV-2. As has been previously shown for HSV-1
(Sawtell, 1997; Sawtell et al., 2001), higher latent loads can
result either from increased numbers of infected neurons or
increased numbers of latent genomes per infected neuron, or
both. To explore these possibilities in detail for HSV-2, we
determined the presence and copy numbers of HSV-2 genomes
in thousands of neurons in culture wells of cells plated from
trigeminal ganglia (TG) from 2 strains of mice, each infected
with a wide range of titers of HSV-2. To render this effort
57Y. Hoshino et al. / Virology 372 (2008) 56–63tractable, we assayed dissociated TG cells by PCR and analyzed
the results using a Poisson distribution which is used for
statistical analyses of infrequent events.
Results
Approximation of the distribution of HSV-2 genome copies in
single infected cells using a Poisson distribution
Data obtained from human TG using laser capture microdis-
section, which isolates single cells for PCR, showed that the
number of genome copies in single neurons is distributed over a
wide range; among HSV genome positive neurons about 40% of
the neurons have 5–10 HSV genome copies, 30% have 10–20
copies, and a lower percentage of neurons have a larger number
of genome copies (Wang et al., 2005). While the genome copy
number determined by laser capture microdissection might be an
underestimate, because only a portion of the neuron nucleus
might be removed from the tissue section, prior studies in our
laboratory showed that the combined efficiency of laser capture
microdissection and PCR in recovering DNA from single
neurons was over 90% (Wang et al., 2005). From the shape of
histogram showing the distribution of HSV-2 genome copies
(Fig. 1), we postulated that a Poisson distribution analysis would
be useful to estimate copy numbers in single infected neurons.
We estimated the number of HSV-2 genome copies in single
neurons by preparing single cell suspensions of TG from BL6
and DBA2 mice latently infected with HSV-2 by the cornea
route, and diluted the cells into wells until a probability analysis
predicted that most wells would contain b2 HSV-infected cells.
We assumed that a single mouse TG contains 100 to 5000 HSV-
infected neurons. Therefore, we diluted suspensions of dissoci-
ated TG cells corresponding to half of a TG in 0.5 to 12 mL of
PBS based on a rough estimate of the total latent viral load from
extract DNA (see below) and plated the cells in 88 wells of 96-
well real-time PCR plates. Analysis of wells for HSV-2 DNA by
real time PCR indicated that while some wells contained low
levels of HSV-2 DNA, most were negative for viral DNA. Thus,
the probability of any well containing ≥2 HSV-infected cellsFig. 1. Distribution of HSV-2 genome copies in positive wells. The histograms
represent the number of wells that contain cells that are positive for HSV-2 by
real-time PCR. The line indicates an approximation of the relative frequency
with an initial mean number of events (mean HSV-2 genome copies per well) of
3.3 that of the distribution of HSV-2 genome copies per well, derived from a
Poisson distribution that has been shifted right by adding 1 to yield 4.3.was relatively small. Therefore, quantitative PCR results for
HSV-2 DNA in plates with a small number of positive reactions
should appropriate the distribution of genome copies in single
infected cells. In one representative experiment with a small
number of positive wells, 37.5% of wells were HSV-2 genome
positive (Fig. 1). Based on Poisson distribution, if the average
number of HSV-2-positive cells per well is a, the expected
frequency of HSV-2-negative wells should be e−a (where e is the
base of natural logarithm). Therefore, the frequency of negative
wells, 0.625, should represented as e−a. Solving for a, the
average number of HSV-2-positive cells per well (=a) should be
0.47 (−Ln of 0.625). Based on this number and assuming a
Poisson distribution for infected cells per well, the probability of
a well containing ≥2 infected cells is 0.08. Therefore among
37.5% of HSV-2 genome positive wells, 21% (8/37.5) should
have ≥2 infected cells. In other words, 79% (100–21%) of
positive wells should contain only one infected cell.
From the pattern of the histogram of the experimental data
(Fig. 1), we chose a shifted Poisson distribution to fit the
observed distribution of HSV-2 genome copies per positive well
(an estimate of genome copies per infected cell), because a
shifted Poisson distribution reasonably fits the data and is
parsimonious. Since the number of HSV-2 genome copies is at
least one per infected cell, the Poisson distribution is shifted one
unit to the right for modeling the number of genome copies (see
Materials and methods). The line in Fig. 1 is a Poisson
distribution fitted to the observed data (histogram) in which the
mean number of events (mean HSV-2 genome copies per well or
infected cell) is 4.3. Thus, a shifted Poisson distribution is a
simple way to model the distribution of HSV-2 genomes per
infected cell.
Estimation of the number of HSV-2-infected cells per well and
mean HSV-2 genome copy per cell
Examination of Fig. 1 shows that the shifted Poisson
distribution with a mean of 4.3 HSV-2 genome copies per well
fits the observed distribution of HSV-2 genome copies per well
when there are ≤7 HSV-2 genome copies per well. However,
wells containing N7 of HSV-2 genome copies (additional peaks
in histogram, Fig. 1) were observed more frequently than
expected from the shifted Poisson distribution. Two hypotheses
could explain this observation— either these wells contain ≥2
HSV-2-infected cells or the findings are due to experimental
variability. We suspect that the former hypothesis is correct,
since the Poisson distribution predicts that if the average
number of infected cells per well is 0.47, about 21% of positive
wells have ≥2 HSV-2-infected cells, as discussed above. To
estimate the actual probability of wells containing ≥2 HSV-2-
infected cells, we used a second Poisson distribution to estimate
the number of HSV-2-infected cells per well. This second
Poisson distribution should account for the additional peaks in
wells containing N7 HSV-2 genome copies (histogram, Fig. 1).
Therefore the observed distribution of HSV-2-positive events
per well can be expressed as the sum of the number of genome
copies per infected cell over the number of infected cells per
well. We assume that the copies per infected cell follows a
Fig. 2. Computer modeling based on a Poisson–Poisson model for HSV-2 genome copies per infected cell and for the numbers of HSV-2-positive cells. Representative
results of PCR and computer simulation of 3 different experiments with different TGs are shown. Cumulative (left panels) and relative (right panels) frequencies of
HSV-2 genome copies per well were measured by real-time PCR. In the left panels, thick dots indicate cumulative frequencies derived from experimental data (real-
time PCR), and thin lines indicate predictions based on computer simulations using the Poisson–Poisson model. In the right panels, the experimental data are shown as
histograms, and thin lines indicate predicted relative frequencies based on computer simulations using the Poisson–Poisson model. Each set of panels was obtained
from a separate experiment. Top panels are from TG 3, middle panels from TG 6, and bottom panels from TG 10 in Table 2.
Table 1
Comparison of the estimated total viral load per trigeminal ganglion obtained by
mathematical modeling using dilutions of cells from HSV-2 infected ganglion
(rows 2 and 3), and by direct extraction of DNA and real-time PCR of cells from







































NA NA NA 5130
NA=not available.
a The number of HSV-2 infected cells/TG was determined by multiplying
(mean number of HSV-2 infected cells/well)× (dilution of TG (mL/TG)×200,
since each PCR well contains 5 μL of TG cell suspension.
b The estimated total viral load/TGwas determined by multiplying (number of
HSV-2 infected cells/TG)×(mean HSV-2 genome copy/infected cell) for the row
labeled Dilution. The estimated total viral load/TG was determined by
multiplying (number of HSV-2 genomes in 200 ng of extracted DNA)×(amount
of DNA extracted from the TG) for the row labeled DNA extraction.
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also follows a Poisson distribution. We call the composite a
Poisson–Poisson model. Using the statistical estimation method
of maximum likelihood, we can find the combination of Poisson
parameters which best fits the observed data. Three different
experiments with different TGs were performed and genome
copies were determined by PCR and computer modeling based
on the Poisson–Poisson model was performed (Fig. 2). The
model based estimated cumulative frequency of HSV-2 genome
copies per well (Fig. 2 left panels, thin lines) fit the observed
data (thick dots in the same panels). Data simulated from the
model recapitulated several of the peaks seen in the relative
frequency of viral genome copies per well obtained from the
PCR data (Fig. 2, right panels). Therefore, the total number of
HSV-2-infected cells can be estimated based on the dilution of
TG applied to PCR plates (i.e. TG cells plated per well) and the
average number of infected cells per well.
Validation of the model
To validate this model, a single cell suspension was prepared
from one latently infected TG from a DBA2 mouse infected with
1×104 pfu of HSV-2 onto the cornea and two different dilutions
were plated and individual wells were assayed for HSV-2 DNA
and analyzed with the Poisson–Poisson model, while anotherfraction of the cell suspension was assayed directly for HSV-2
DNA. Different dilution factors affect the Poisson distribution for
the number of HSV-2 infected cells per well, but not for the mean
Table 2





Mean number of HSV-2
genome copies/cell(95%CI)
Number of HSV-2 infected
cells/TGb (95%CI)
Estimated latent viral
load/TG by model c
Latent viral load/TG
by extraction d
1 DBA2 1250 5.1 (4.2, 6.1) 128 (125, 131) 648 1080
2 DBA2 2500 7.0 (5.5, 8.4) 76 (74, 78) 533 1640
3 DBA2 160,000 27.0 (24.7, 29.0) 1370 (1365, 1385) 37,000 57,000
4 DBA2 160,000 34.7 (29.1, 43.0) 2800 (2761, 2826) 97,000 221,000
5 BL6 625 5.7 (4.8, 6.6) 136 (134, 139) 768 852
6 BL6 2500 16.1 (13.1, 17.5) 1940 (1927, 1957) 31,200 23,300
7 BL6 2500 28.8 (26.8 30.4) 1460 (1455, 1474) 42,200 89,700
8 BL6 5000 16.7 (14.8, 19.4) 1970 (1956, 1988) 32,900 44,300
9 BL6 5000 7.8 (6.9, 8.8) 952 (945, 961) 7440 3920
10 BL6 5000 14.1 (12.6, 15.5) 452 (446, 458) 6390 19,200
11 BL6 5000 5.3 (3.7, 7.3) 14 (13.3, 15.1) 74 68
12 BL6 5000 11.2 (9.5, 13.2) 1420 (1409, 1440) 16,000 19,200
13 BL6 5000 9.8 (8.4, 11.2) 831 (822, 841) 8180 8570
14 BL6 20,000 24.8 (22.6, 26.9) 4220 (4206, 4244) 105,000 32,500
15 BL6 20,000 15.5 (14.1, 16.9) 3020 (3010, 3040) 47,000 98,400
16 BL6 20,000 9.4(7.2, 11.1) 5390 (5359, 5437) 50,500 61,900
17 BL6 20,000 16.8 (11.9, 19.1) 3500 (3477, 3558) 58,900 53,700
a In some cases, pairs of TGs were evaluated from the same animal. TG 3 and 4, 6 and 7, 8 and 9, 10 and 11, 12 and 13, 14 and 15, 16 and 17 are each left and right
TG from the same animal.
b The number of HSV-2 infected cells/TG was determined by multiplying (number of HSV-2 infected cells/well)×(dilution of TG [mL/TG])×200.
c The estimated viral load/TG was calculated by multiplying (mean number of HSV-2 genome copies)× (number of HSV-2-infected cells/TG).
d The latent viral load/TG by extraction was calculated by multiplying (number of HSV-2 DNA copies in 200 ng of DNA)×(total amount of DNA extracted from the
TG cell suspension).
Fig. 3. Comparison of total viral loads obtained experimentally by extraction of
ganglia DNA and from computer simulation using the Poisson–Poisson model.
The latent viral load from extracted DNAwas calculated by performing real-time
PCR using 200 ng of ganglia DNA and then correcting for the total amount of
DNA per ganglia. The total viral load from computer simulation using the
Poisson–Poisson model was calculated by multiplying the number of infected
cells/TG by the mean number of HSV-2 genome copies per infected cell (see
Table 2). Closed circles represent data obtained from C57BL6 mice; open
squares represent data from DBA2 mice. The equation was derived from the
linear regression line in the panel.
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fraction of the cell suspension was diluted at 2 mL per TG and an
equivalent fraction was diluted at 8 mL per TG; each were then
distributed into 88 wells of a real-time PCR plate. Real-time PCR
and mathematical analyses were done independently for the two
plates. DNAwas extracted from the second fraction of the TG cell
suspension and the HSV-2 DNA load was determined by real-
time PCR. The numbers of HSV-2-infected cells per well were
different due to the different dilution factors, but themean number
of HSV-2 infected cells per TG and HSV-2 genome copies per
infected cell from the two dilutions were reasonably close
(Table 1). When the latent viral loads of the TG in Table 1 were
estimated using the mathematical method (number of HSV-2
infected cells per TG multiplied by the mean HSV-2 genomes
copies per infected cell) and compared with the viral load based
on extracted DNA from the ganglia, the numbers were 4700
copies of HSV-2 DNA for the 2 mL per TG dilution, 3790 copies
for the 8 mL per TG dilution, and 5130 copies for the DNA
extract. The similarity of these results indicates that the mathe-
matical model, based on the Poisson–Poisson model, provides a
reasonable approximation of the true viral load.
This model assumes that all of the HSV-2 genomes are
present inside of the cells and that no viral DNA is released from
cells after collagenase treatment. Therefore we tested for HSV-2
DNA in the supernatants after collagenase treatment. None of
176 wells of supernatant derived from 4 TGs were positive for
HSV-2 DNA. Therefore most, if not all, of the HSV-2 DNA
remains inside the cells after collagenase treatment.
To further validate the results, we performed several
experiments with two strains of mice and different doses of
inocula in which we compared (a) the latent viral load per TGderived by multiplying the number of infected cells/TG times
the mean HSV-2 genome copies per infected cell (obtained from
the Poisson–Poisson model) with (b) the viral load obtained by
PCR of 200 ng of DNA extracted from ganglia and then
corrected for the total amount of DNA in the ganglia (Table 2).
When the data in Table 2 were plotted on a log scale, the
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and from the Poisson–Poisson model was highly correlated
(R=0.96, Fig. 3). The slope of the regression line was 0.96
(95% CI, 0.82, 1.10) compared with an expected value of 1.0,Fig. 4. Relationship between the latent viral load, the number of HSV-2 infected
cells per TG, and the mean HSV-2 genome copies/infected cell. The number of
HSV-2 infected cells per TG (Panel A) and the mean number of HSV-2 genome
copies per infected cell (Panel B) are compared with the latent viral loads. Panel
C shows the correlation between the number of HSV-2 infected cells per TG
(x-axis) and the mean number of HSV-2 genome copies per infected cell (y-axis).
Linear regression lines are shown in the scale of log10 and equations of
regression and R-values were derived from the lines. Closed circles represent
data obtained from C57BL6 mice; open squares represent data from DBA2
mice.and the y intercept was 0.08 (95% CI, −1.3, 1.5) compared with
an expected value of 0.
The latent load of HSV-2 in mouse ganglia is a linear function
of both the number of infected neurons and the number of latent
genome copies per neuron
The numbers of HSV-2 infected cells per TG ranged from 14
to 5390 (Table 2). For the 13 TG from BL6 mice, the number of
HSV-2 infected cells per TG and the doses of the inocula
correlated significantly (p=0.013 by Spearman's Rho test).
When the number of HSV-2 infected cells per TG (log10) was
plotted against the total latent viral load from extracted DNA per
TG (log10), a substantial linear correlation was noted (R=0.92,
Fig. 4A).When the two strains of mice were analyzed separately,
the slopes of regression lines of the two strains were very close
(0.72 and 0.67 for BL6 and DBA2, respectively). Thus, the
linear relationship between the latent viral load and the number
of HSV-2 infected cells was similar for both strains of mice.
However, analysis of covariance showed that the numbers of
HSV-2 infected cells in BL6 mice were significantly higher than
those in DBA2 mice (p=0.04), although the difference was
small (1.5-fold). This difference might be due to different
methods of infection (corneal scarification in BL6 mice vs. no
scarification in DBA2 mice), differences in the genetic back-
grounds of the mice, or difference in doses of the inoculum.
We found that the mean number of HSV-2 genome copies
per cell ranged from 5.1 to 34.7 (Table 2). The mean number of
HSV-2 genome copies per cell (log10) also correlated strongly
with the total latent viral load from extracted DNA per TG
(log10) (R=0.86, Fig. 4B). When the two strains of mice were
analyzed separately, the slopes of the regression lines and their
y-axis intersects were similar (y=0.20x+0.26 for BL6 and
y=0.36x−0.35 for DBA2, respectively). Thus, when plotted on
a log scale, the latent viral load as determined by extraction
correlated with both the number of HSV-2 infected cells/TG and
the HSV-2 genome copy/cell in a linear fashion, and these
correlations were similar in the 2 strains of mice. When the
mean number of HSV-2 genomes per cell (log10) was plotted
against the number of HSV-2 infected cells per TG (log10), a
significant linear correlation was noted (p=0.001, Fig. 4C).
This suggests that the number of HSV-2 genomes per cell is not
independent of the number of infected cells, and that similar
factors, such as the titer of inocula, and the multiplicity of
infection in cornea cells influences both the number of viral
genomes per cell and the number of infected cells.
Discussion
In this study we have shown that in HSV-2 latently infected
mouse TG, there were 14 to 5390 infected cells per TG (median
1424), and the mean number of HSV-2 genome copies per cell
was from 5.1 to 34.7 (median 14.1). Based on the size and the
morphology of cells we estimate that there are 10,000 neurons in
a mouse TG, which is consistent with a prior estimate (Liu et al.,
2001). In contrast, other reports calculated 17,000 to 25,000
neurons in a mouse TG (Liebl et al., 1997; Liu et al., 2000;
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staining with antibody to neurofilament 200, which is more
sensitive than our simple identification based on size and
morphology. It is possible that we have underestimated the
number of neurons. If we assume that only neurons contain
latent HSV, then the frequency of neurons with latent HSV in the
mouse is 20–50% (5390/10,000 to 5390/25,000) depending on
the titer of the infectious inoculum and on the latent viral load.
Sawtell and colleagues performed semi-quantitative PCR using
known numbers of fixed neurons frommouse trigeminal ganglia
and reported that the frequency of HSV-1 infected neurons was
b1% to 30% (Sawtell, 1997, 1998; Sawtell et al., 1998, 2001).
Thus, the frequencies of HSV-2 latently infected neurons that we
calculated were similar to HSV-1 latently infected neurons esti-
mated by Sawtell and colleagues. Furthermore, Sawtell showed
that the number of HSV-1 genomes in single infected cells
ranged over a thousand-fold (Sawtell, 1997). Using real-time
PCR, we found 4 to 1500 HSV-2 DNA copies/well, although
95% of wells contained less than 250 HSV-2 DNA copies.
Wang and colleagues performed real-time PCR on individual
human neurons obtained by laser capture microdissection and
found that 2 to 11% of neurons from human TGwere positive for
HSV-1 and that the median copy number of HSV genomes in
infected cells was 11.3 (Wang et al., 2005). We found that mice
receiving the lowest titers of inocula (625 PFU and 1,250 PFU
for BL6 and DBA2, respectively, Table 2) had 82 to 136 HSV-2
infected cells per TG; therefore, about 0.4–1% of cells were
latently infected. Thesemice had amean of 4 to 6 copies of HSV-
2 DNA per infected cell. Thus, with a low titer of inocula (which
we suspect may bemore relevant to the titers that occur in human
HSV infections), the frequency of HSV infected neurons and the
viral copy number per infected cell in HSV-2 latently infected
mice was similar to that observed in HSV-1 latently infected
humans.
We found that both the log10 of the number of HSV-2 infected
cells per TG and the log10 of the mean copy number of HSV-2
genomes per infected cell were a linear function of the log10 of
the latent viral load (Figs. 4A and B). Interestingly, the slopes of
the regression lines in each strain of mice were similar,
suggesting that the relationship between the latent viral load
and the number of HSV-2 infected cells per TG or the mean copy
number of HSV-2 genomes per infected cell is independent of
the strain of mouse. Since the estimated latent viral load is the
product of the number of infected cells times the mean number of
HSV genome copies per infected cell, the sum of the slopes of
the two regression lines in Figs. 4A andB should be 1. In fact, the
sum of the slopes of the regression lines in Figs. 4A and B was
0.96 (0.71+0.25), which is consistent with the high correlation
coefficient shown in Fig. 3.
The latent viral load is one of themost important determinants
of the rate of reactivation in explant ganglia in mice (Hoshino
et al., 2007;Maggioncalda et al., 1996) and the guinea pig model
(Hoshino et al., 2005; Lekstrom-Himes et al., 1998); however, it
is uncertain if one or both of the two components of the latent
viral load, the number of infected neurons or the genome copy
number in infected cells, is of primary importance in deter-
mining the rate of reactivation. Thompson and Sawtell (2000)reported that the number of infected neurons in TG is more
important than the number HSV genomes per neuron. Sawtell
showed that the genome copy number in infected cells is also an
important factor for reactivation (Sawtell, 1997; Sawtell et al.,
1998). Our observation of the significant linear correlations
among the total viral load, the number of HSV-2 infected cells,
and the mean HSV-2 genome copy in infected cells indicates that
these factors are not independent, and therefore that both the
latent viral load and the number of infected neurons are
important for determining the frequency of reactivation in
explant ganglia. Previously, we showed that prophylactic
vaccines reduce recurrent genital herpes in guinea pigs by
reducing acute disease and reducing the latent viral load. Since
the latent viral load correlates with the rate of recurrences, a
prophylactic vaccine should reduce both the number of HSV-




HSV-2 strain 333 was propagated and titered in Vero cells, as
described previously (Hoshino et al., 2005). Nine- to 10-week-
old C57BL6 or DBA2 mice were infected with HSV-2 strain
333 at various doses ranges (6.25×102 to 2.0×104 PFU for
BL6 mice, 2.5×103 to 1.6×105 PFU for DBA2 mice) onto both
of their scarified (C57BL6) or not scarified (DBA2) corneas.
Human IgG (1:8 dilution in PBS, 0.5 mL/animal) was ad-
ministered intraperitoneally so that most infected mice would
survive acute infection and maintain long-term latency (Dalai
et al., 2002).
Preparation of 88-well aliquots of cells from
trigeminal ganglia
At 29 to 33 days after infection mice were sacrificed and their
TG were harvested aseptically. One TG from each mouse was
frozen immediately at −80 °C for later PCR assay of the total
latent viral load, while the contralateral TG from each mouse
was dispersed with collagenase Type I (Sigma-Aldrich, St.
Louis, MO, 3 mg/mL, 37 °C for 1–1.5 h) into a single cell
suspension (Hoshino et al., 2005), heated for 30 min at 95 °C to
inactivate the collagenase, washed, and resuspended in TE
buffer (10 mM Tris HCl pH 8.0, 1 mM EDTA). Aliquots of
dispersed cells equivalent to half of each TG were stored at
−80 °C. We assumed that each TG contains about 100 to 5000
HSV-2-infected cells based on an estimate of 10,000–25,000
neurons in a mouse TG (Liebl et al., 1997; Liu et al., 2001, 2000;
Sawtell, 1997). The remainder of each cell suspension was
diluted in 0.5 to 12 mL of PBS to yield an average of 0.5 to 3
HSV-2-infected cells/well. The TG cell suspensions were plated
into 88 wells of Optical 96-well reaction plates (PE Applied
Biosystem) and DNA was extracted by addition of TE buffer
supplemented with proteinase K (0.4 mg/mL, Sigma) and Tween
20 (1%; Sigma). Each plate was incubated at 55 °C for 1 hr
followed by inactivation of proteinase K for 15 min at 75 °C.
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2 mice were infected with 2.0×104 PFU of HSV-2 and
6 weeks from infection, 4 TGs were dispersed in collagenase
as described. After the cells were centrifuged, the remaining
supernatants were transferred to another tube and heated to 95 °C
for 30 min to inactivate the collagenase. Supernatants were
plated into 96-well PCR plates (44 wells for each TGwith 5 ul of
supernatant per well), treated with proteinase K and Tween 20 as
described above, and the number of HSV-2 genome copies was
measured.
To determine if the single cell suspension actually contained
clumps of cells, 4 TGs from 2 mice were dissociated with
collagenase, washed with PBS, fixed with 70% ethanol, and
washed again. The cells were then treated with 50 μL of RNAse
A (Sigma) for 30 min at 37 °C, and stained with propidium
iodide (5 μg/mL). Flow cytometry was performed using a FACS
Caliber (Becton Dickinson, Franklin Lakes, NJ) and cell clumps
were identified in the plot of FL2-area versus FL2-width. The
frequency of clumped cells was 4.2–5.9%.
Real-time quantitative PCR
Real-time PCR for HSV-2 DNAwas performed on extracts of
each well of dissociated TG cells using a Taqman System, ABI
7700 Sequence Detector (PE Applied Biosystem, Foster City,
CA) with primers and probes specific for HSV 2 glycoprotein D
(gD2) sequences (Dalai et al., 2002). The sequence of the forward
primer was, 5′-TCAGCGAGGATAACCTGGGA-3′, and the re-
verse primer was, 5′-GGGAGAGCGTACTTGCAGGA-3′. The
probe was TAMRA-5′-CCAGTCGTTTATCTTCACTAGCCG-
CAGGTA-3′. A standard curve with known numbers of copies of
a gD2-containing plasmid diluted in salmon spermDNAwas used
to determine copy numbers. The lower limit of this PCR assay
was ∼4 copies/reaction with excellent linearity (RN0.92) over 4
logs of DNA content. Addition of uninfected cells did not inhibit
PCR of HSV-2 DNA in infected cells until about 10,000
uninfected cells were added per well.
DNA was also extracted from frozen cell suspensions each
equivalent to a half TGusing a PuregeneDNA isolation kit (Gentra
Systems, Minneapolis, Minnesota) and the number of HSV-2
genome copies was determined from 200 ng of extracted DNA
using real-time PCR. The amount of DNA extracted from a TG
was 8.7±1.3 μg/TG (mean±S.E.) measured by spectrophoto-
metry. The total latent DNAviral load was calculated based on the
fraction of total gangliaDNA thatwas assayed in thePCR reaction.
Computational and statistical analysis
We used separate Poisson models to obtain the mean
number of HSV-2-infected cells per TG and the mean number of
HSV-2 genome copies per infected cell. Since the number
of genome copies is at least one within an infected cell, the
Poisson distribution is shifted one unit for modeling the number
of genome copies. Thus if we denote the number of genome
copies for a given well as Y, the number of genome copies for a
given cell as W, and the number of infected cells as X, we have
Y=W1+W2+…WX, with Y=0 if X=0. We assume that X has aPoisson distribution with parameter λ and each W−1 has a
Poisson distribution with parameter β. It is difficult to obtain
reproducible results at less than 4 copies without assaying very
large numbers of wells. Any genome copy numbers less than 4
were treated as censored over the interval 1 to 4, because the
genome copy generated from standard curve is not fully reliable
near the limit of detection and unequal distributions of viral
genomes in each well. The observed data are skewed since there
are a few wells with a large number of genome copies; thus, the
variance of the sample is up to 100 times that of the sample
mean. Some of the variation may be due to cells that are
clumped together. In order to obtain a robust result, a truncated
likelihood method was used. Any well where the number of
genome copies exceeded 3 standard deviations of the sample
mean was discarded. The truncated likelihood appropriately
adjusts for this discarding rule in obtaining estimates of the
Poisson parameters. The number of discarded wells was 0 in 3
plates, 1 in 5 plates, 2 in 6 plates, 3 in 2 plates, 4 in 1 plate out of
17 plates each of which contained 88 wells. The fraction of
HSV-2 genome copies in discarded wells was 12.4±1% (mean±
S.E.) of the total of HSV-2 genomes in each. The method of
maximum likelihood was used to estimate λ and β. The 95%
confidence intervals were provided by using the likelihood ratio
statistic (Cox and Hinkley, 1974; Lehmann, 1983). For a
sensitivity analysis, we also used a skewed model where the
number of genome copies per cell minus 1, followed a negative
binomial distribution, while the number of infected cells per well
followed a Poisson distribution. The results of the two analyses
were similar. Statistical analysis was done using Splus 5 for Unix
software (Mathsoft, Inc. Seattle, WA).
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